You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
H&M: We believe Q3 has been tough
We believe H&M’s demand has remained sluggish in Q3, while the company faces several headwinds on the gross margin. H2 is set out to be softer than we previously expected, and we lower our estimates for 2024-2025. Analyst Rauli Juva summarizes.
Content:
00:00 Start
00:07 Weak demand in June, challenging market
00:51 We have lowered our estimates
01:41 Growth going forward
Read the latest research: We believe Q3 has been tough, published 2024-08-29
Do you have questions to our analyst regarding H&M: Welcome to our forum!
Read more research on H&M !
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
View all videos